The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis
Abstract
Mutations in alpha-synuclein, a protein highly enriched in presynaptic terminals, have been implicated in the expression of familial forms of Parkinson's disease (PD) whereas native alpha-synuclein is a major component of intraneuronal inclusion bodies characteristic of PD and other neurodegenerative disorders. Although overexpression of human alpha-synuclein induces dopaminergic nerve terminal degeneration, the molecular mechanism by which alpha-synuclein contributes to the degeneration of these pathways remains enigmatic. We report here that alpha-synuclein complexes with the presynaptic human dopamine transporter (hDAT) in both neurons and cotransfected cells through the direct binding of the non-A beta amyloid component of alpha-synuclein to the carboxyl-terminal tail of the hDAT. alpha-Synuclein--hDAT complex formation facilitates the membrane clustering of the DAT, thereby accelerating cellular dopamine uptake and dopamine-induced cellular apoptosis. Since the selective vulnerability of dopaminergic neurons in PD has been ascribed in part to oxidative stress as a result of the cellular overaccumulation of dopamine or dopamine-like molecules by the presynaptic DAT, these data provide mechanistic insight into the mode by which the activity of these two proteins may give rise to this process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway
Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., & Davis, R. J. (2000) · Science · doi:10.1126/science.288.5467.870 · Cited by 1,728
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species
Kane, D., Sarafian, T., Anton, R., Hahn, H., Gralla, E., Valentine, J., Ord, T., & Bredesen, D. (1993) · Science · doi:10.1126/science.8235659 · Cited by 1,671
(1998) · Europe PMC (PubMed Central) · Cited by 1,594
Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes
Davidson, W. S., Jonas, A., Clayton, D. F., & George, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9443 · Cited by 1,585
NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively Unfolded
Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A., & Lansbury, P. T. (1996) · Biochemistry · doi:10.1021/bi961799n · Cited by 1,523
Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,499
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,480
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316
Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291
Javitch, J. A., D'Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,263
Identification of two distinct synucleins from human brain
Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080
Tu, P., Galvin, J. E., Baba, M., Giasson, B., Tomita, T., Leight, S., Nakajo, S., Iwatsubo, T., Trojanowski, J. Q., & Lee, V. M. ‐. (1998) · Annals of Neurology · doi:10.1002/ana.410440324 · Cited by 686
Dopamine transporter density in patients with attention deficit hyperactivity disorder
Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K., & Fischman, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04030-1 · Cited by 684
Berman, S. B., & Hastings, T. G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731127.x · Cited by 664
Profound neuronal plasticity in response to inactivation of the dopamine transporter
Jones, S. R., Gainetdinov, R. R., Jaber, M., Giros, B., Wightman, R. M., & Caron, M. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.4029 · Cited by 600
α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins
Ostrerova, N., Petrucelli, L., Farrer, M., Mehta, N., Choi, P., Hardy, J., & Wolozin, B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05782.1999 · Cited by 564
Biochemical aspects of Parkinson's disease
Hornykiewicz, O. (1998) · Neurology · doi:10.1212/wnl.51.2_suppl_2.s2 · Cited by 564
Prospects for new restorative and neuroprotective treatments in Parkinson's disease
Dunnett, S. B., & Björklund, A. (1999) · Nature · doi:10.1038/399a032 · Cited by 537
Lippa, C. F., Fujiwara, H., Mann, D. M. A., Giasson, B., Baba, M., Schmidt, M. L., Nee, L. E., O'Connell, B., Pollen, D. A., St. George-Hyslop, P., et al. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65722-7 · Cited by 533
Constitutive Phosphorylation of the Parkinson's Disease Associated α-Synuclein
Okochi, M., Walter, J., Koyama, A., Nakajo, S., Baba, M., Iwatsubo, T., Meijer, L., Kahle, P. J., & Haass, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.390 · Cited by 519
Physiology and Anatomy of Possible Oscillators in the Central Nervous System
Rothwell, J. C. (2008) · Movement Disorders · doi:10.1002/mds.870131304 · Cited by 511
Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions
Engelender, S., Kaminsky, Z., Guo, X., Sharp, A. H., Amaravi, R. K., Kleiderlein, J. J., Margolis, R. L., Troncoso, J. C., Lanahan, A. A., Worley, P. F., et al. (1999) · Nature Genetics · doi:10.1038/8820 · Cited by 489
Nirenberg, M., Vaughan, R., Uhl, G., Kuhar, M., & Pickel, V. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-02-00436.1996 · Cited by 480
Synucleins in synaptic plasticity and neurodegenerative disorders
Clayton, D. F., & George, J. M. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991001)58:1<120::aid-jnr12>3.0.co;2-e · Cited by 442
Liu, F., Wan, Q., Pristupa, Z. B., Yu, X.-M., Wang, Y. T., & Niznik, H. B. (2000) · Nature · doi:10.1038/35002014 · Cited by 431
Self-citationJenco, J. M., Rawlingson, A., Daniels, B., & Morris, A. J. (1998) · Biochemistry · doi:10.1021/bi972776r · Cited by 431
Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro
Hashimoto, M., Hsu, L. J., Xia, Y., Takeda, A., Sisk, A., Sundsmo, M., & Masliah, E. (1999) · NeuroReport · doi:10.1097/00001756-199903170-00011 · Cited by 429
Degradation of α-Synuclein by Proteasome
Bennett, M. C., Bishop, J. F., Leng, Y., Chock, P. B., Chase, T. N., & Mouradian, M. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.33855 · Cited by 417
Irizarry, M. C., Growdon, W., Gomez-isla, T., Newell, K., George, J. M., Clayton, D. F., & Hyman, B. T. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199804000-00005 · Cited by 394
Jensen, P. H., Hager, H., Nielsen, M. S., Højrup, P., Gliemann, J., & Jakes, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25481 · Cited by 377
Membrane Trafficking Regulates the Activity of the Human Dopamine Transporter
Melikian, H. E., & Buckley, K. M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-07699.1999 · Cited by 374
Dopamine transporters and neuronal injury
Miller, G. W., Gainetdinov, R. R., Levey, A. I., & Caron, M. G. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01379-6 · Cited by 371
El-Agnaf, O. M. A., Jakes, R., Curran, M. D., Middleton, D., Ingenito, R., Bianchi, E., Pessi, A., Neill, D., & Wallace, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01418-5 · Cited by 363
Regulated Trafficking of the Human Dopamine Transporter
Daniels, G. M., & Amara, S. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35794 · Cited by 352
Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture
Michel, P. P., & Hefti, F. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490260405 · Cited by 338
Halestrap, A. P., Doran, E., Gillespie, J. P., & O'Toole, A. (2000) · Biochemical Society Transactions · doi:10.1042/bst0280170 · Cited by 321
Lavedan, C. (1998) · Genome Research · doi:10.1101/gr.8.9.871 · Cited by 320
Dopamine Induces Apoptosis through an Oxidation-involved SAPK/JNK Activation Pathway
Luo, Y., Umegaki, H., Wang, X., Abe, R., & Roth, G. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3756 · Cited by 310
MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons
Kowall, N. W., Hantraye, P., Brouillet, E., Beal, M. F., McKee, A. C., & Ferrante, R. J. (2000) · NeuroReport · doi:10.1097/00001756-200001170-00041 · Cited by 291
Hersch, S. M., Yi, H., Heilman, C. J., Edwards, R. H., & Levey, A. I. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971117)388:2<211::aid-cne3>3.0.co;2-4 · Cited by 291
Vaughan, R. A., Huff, R. A., Uhl, G. R., & Kuhar, M. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15541 · Cited by 290
Han, H., Weinreb, P. H., & Lansbury, P. T. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90071-3 · Cited by 284
El-Agnaf, O. M. A., Jakes, R., Curran, M. D., & Wallace, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01419-7 · Cited by 258
Trojanowski, J. Q., & Lee, V. M.-Y. (1998) · Archives of Neurology · doi:10.1001/archneur.55.2.151 · Cited by 254
Role of Cytochrome c as a Stimulator of α-Synuclein Aggregation in Lewy Body Disease
Hashimoto, M., Takeda, A., Hsu, L. J., Takenouchi, T., & Masliah, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.28849 · Cited by 236
Withers, G. S., George, J. M., Banker, G. A., & Clayton, D. F. (1997) · Developmental Brain Research · doi:10.1016/s0165-3806(96)00210-6 · Cited by 235
Functional hyperdopaminergia in dopamine transporter knock-out mice
Gainetdinov, R. R., Jones, S. R., & Caron, M. G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00122-5 · Cited by 232
Cell death mechanisms in Parkinson's disease
Jellinger, K. A. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050001 · Cited by 226
Irizarry, M. C., Kim, T.-W., MCNamara, M., Tanzi, R. E., George, J. M., Clayton, D. F., & Hyman, B. T. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199608000-00004 · Cited by 205
Yoshimoto, M., Iwai, A., Kang, D., Otero, D. A., Xia, Y., & Saitoh, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9141 · Cited by 203
Bunn, R. C., Jensen, M. A., & Reed, B. C. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.819 · Cited by 196
Metals and free radicals in neurodegeneration
Olanow, C. W., & Arendash, G. W. (1994) · Current Opinion in Neurology · doi:10.1097/00019052-199412000-00013 · Cited by 193
Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?
Mezey, E., Dehejia, A., Harta, G., Papp, M. I., Polymeropoulos, M. H., & Brownstein, M. J. (1998) · Nature Medicine · doi:10.1038/nm0798-755 · Cited by 184
Modification of Dopamine Transporter Function: Effect of Reactive Oxygen Species and Dopamine
Berman, S. B., Zigmond, M. J., & Hastings, T. G. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020593.x · Cited by 179
Pristupa, Z. B., McConkey, F., Liu, F., Man, H., Lee, F. J. S., Wang, Y. T., & Niznik, H. B. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199809)30:1<79::aid-syn10>3.0.co;2-k · Cited by 176
Self-citationBignami, G. F. (1999) · Nature · doi:10.1038/19899 · Cited by 163
Regulation of the functional activity of the human dopamine transporter by protein kinase C
Zhang, L., Coffey, L. L., & Reith, M. E. A. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00898-2 · Cited by 159
Wu, R., Chiueh, C. C., Pert, A., & Murphy, D. L. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90181-g · Cited by 152
Jensen, P. H., Højrup, P., Hager, H., Nielsen, M. S., JACOBSEN, L., Olesen, O. F., Gliemann, J., & Jakes, R. (1997) · Biochemical Journal · doi:10.1042/bj3230539 · Cited by 144
Pharmacology and regulation of the neuronal dopamine transporter
Reith, M. E. A., Xu, C., & Chen, N. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00065-4 · Cited by 137
Protein Kinase C Regulates the Interaction between a GABA Transporter and Syntaxin 1A
Beckman, M. L., Bernstein, E. M., & Quick, M. W. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06103.1998 · Cited by 137
Luo, Y., Hattori, A., Munoz, J. R., Qin, Z.-H., & Roth, G. S. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.2.254 · Cited by 120
Striatal Dopaminergic Abnormalities in Human Cocaine Users
Little, K. Y., Zhang, L., Desmond, T., Frey, K. A., Dalack, G. W., & Cassin, B. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.238 · Cited by 116
Aberrant Protein Deposition and Neurological Disease
Kaytor, M. D., & Warren, S. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37507 · Cited by 113
Nirenberg, M. J., Chan, J., Vaughan, R. A., Uhl, G. R., Kuhar, M. J., & Pickel, V. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04037.1997 · Cited by 112
?-Synuclein expression in substantia nigra and cortex in Parkinson's disease
Neystat, M., Lynch, T., Przedborski, S., Kholodilov, N. G., Rzhetskaya, M., & Burke, R. E. (1999) · Movement Disorders · doi:10.1002/1531-8257(199905)14:3<417::aid-mds1005>3.0.co;2-x · Cited by 103
Protein kinase C activators decrease dopamine uptake into striatal synaptosomes.
Copeland, B. J., Vogelsberg, V., Neff, N. H., & Hadjiconstantinou, M. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13104-2 · Cited by 97
Synoretin—A New Protein Belonging to the Synuclein Family
Surguchov, A. P., Surgucheva, I. G., Solessio, E. C., & Baehr, W. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0735 · Cited by 96
Nirenberg, M. J., Chan, J., Vaughan, R. A., Uhl, G. R., Kuhar, M. J., & Pickel, V. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05255.1997 · Cited by 88
Forloni, G., Bertani, I., Calella, A. M., Thaler, F., & Invernizzi, R. W. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<632::aid-ana11>3.0.co;2-n · Cited by 82
Role of Mitochondria in Parkinson Disease
Kösel, S., Hofhaus, G., Maaßen, A., Vieregge, P., & Graeber, M. B. (1999) · Biological Chemistry · doi:10.1515/bc.1999.106 · Cited by 71
Bodles, A. M., Guthrie, D. J. S., Harriott, P., Campbell, P., & Irvine, G. B. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01219.x · Cited by 69
Changes and new features in Neurology
Griggs, R. C. (1998) · Neurology · doi:10.1212/wnl.51.1.2 · Cited by 68
Kholodilov, N. G., Oo, T. F., & Burke, R. E. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00740-5 · Cited by 65
The Dopamine Transporter Carboxyl-terminal Tail
Lee, F. J. S., Pristupa, Z. B., Ciliax, B. J., Levey, A. I., & Niznik, H. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20885 · Cited by 56
Self-citationThe Glut 1 Glucose Transporter Interacts with Calnexin and Calreticulin
Oliver, J. D., Hresko, R. C., Mueckler, M. M., & High, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13691 · Cited by 43
Cocaine Upregulates the Dopamine Transporter in Fetal Rhesus Monkey Brain
Fang, Y., & Rønnekleiv, O. K. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08966.1999 · Cited by 40
Offen, D., Hochman, A., Gorodin, S., Ziv, I., Shirvan, A., Barzilai, A., & Melamed, E. (1999) · PubMed · Cited by 38
Ciliax (1999) · doi:10.1002/(sici)1096-9861(19990621)409:1<38::aid-cne4>3.0.co;2-1
Cited by
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,280
Plasma membrane monoamine transporters: structure, regulation and function
Torres, G. E., Gainetdinov, R. R., & Caron, M. G. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1008 · Cited by 939
Cabin, D. E., Shimazu, K., Murphy, D., Cole, N. B., Gottschalk, W., McIlwain, K. L., Orrison, B., Chen, A., Ellis, C. E., Paylor, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08797.2002 · Cited by 865
Metadata
- Authors
- LEE, F. J. S., LIU, F., PRISTUPA, Z. B., & NIZNIK, H. B.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-04
- Volume
- 15
- Issue
- 6
- Pages
- 916-926
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2074920372
- Cited by
- 455
- References
- 86
- FWCI
- 24.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.